Genetics of nearby healthy tissue may help catch lung cancer's return

日本 ニュース ニュース

Genetics of nearby healthy tissue may help catch lung cancer's return
日本 最新ニュース,日本 見出し
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 51%

Genetic information collected from seemingly healthy tissue near lung tumors may be a better predictor of whether cancer will come back after treatment than analysis of the tumors themselves, according to new research led by NYU Langone Health and its Perlmutter Cancer Center.

retrieved 8 November 2023 from https://medicalxpress.com/news/2023-11-genetics-nearby-healthy-tissue-lung.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Mar 1, 2023Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

medical_xpress /  🏆 101. in UK

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

NYU Langone Health earns Leapfrog's top safety ratings for the seventh time in a rowNYU Langone Health earns Leapfrog's top safety ratings for the seventh time in a rowFor the seventh time in a row, NYU Langone Health has earned top safety ratings for its inpatient locations across the system, with each receiving 'A' ratings in the fall 2023 Leapfrog Hospital Safety Grade release, a level of patient safety achieved by only 30 percent of hospitals nationwide.
続きを読む »

Epidemiology and genetics of clonal hematopoiesis, a premalignant hematopoietic stem cell conditionEpidemiology and genetics of clonal hematopoiesis, a premalignant hematopoietic stem cell conditionA comprehensive new study from deCODE genetics published in Nature Genetics, provides insights into the epidemiology and somatic and germline genetics of clonal hematopoiesis.
続きを読む »

Q&A: Researcher discusses genetics and biomarkers of frailty thesisQ&A: Researcher discusses genetics and biomarkers of frailty thesisFrailty is an age-related state of physiological decline and is a strong predictor of disability and mortality. Researchers are trying to improve our understanding of the biology of frailty and to find ways of identifying frail older adults with the aim to improve individualized management of frailty.
続きを読む »

Study reveals genetic chain reaction that drives the spread of prostate cancerStudy reveals genetic chain reaction that drives the spread of prostate cancerNew research from scientists at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) determined that a particular gene—MDA-9/Syntenin-1/SDCBP—is the ringleader behind a molecular domino effect driving prostate cancer growth and metastasis.
続きを読む »

Genetic architecture may be key to using peacekeeping immune cells to treat autoimmunity or fight cancerGenetic architecture may be key to using peacekeeping immune cells to treat autoimmunity or fight cancerRegulatory T cells are specialized immune cells that suppress the immune response and prevent the body from attacking its own cells. Understanding how these cells work is key to determining how they might be manipulated to encourage the destruction of cancer cells or prevent autoimmunity.
続きを読む »

Lung cancer researchers identify specific genetic change that predicts whether patients can respond to targeted therapyLung cancer researchers identify specific genetic change that predicts whether patients can respond to targeted therapySquamous cell lung cancer is a lung cancer subtype that is particularly difficult to treat. A new study now has revealed a novel genetic alteration that occurs in some cases in this type of tumor and that may expose a weakness of the tumor for therapeutic intervention.
続きを読む »



Render Time: 2025-03-31 16:00:06